The FDA awarded 510(k) clearance to Flexicath for its pressure injectable M/29 Midterm catheters, the company announced last week.
The Pittsburgh-based catheter insertion systems maker aims to address "blood stream infection control issues" with its devices, according to a press release.
The M/29 Midterm features built-in 360-degress Maximum Barrier technology for preventing airborne and touch-borne contamination during catheter insertion, according to the company.
The line also features ultrasound assisted placement and contrast agent administration, in addition to pressure injection rating up to 5 ml per second.